These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 29227986)
1. Bcl-2 on the brink of breakthroughs in cancer treatment. Reed JC Cell Death Differ; 2018 Jan; 25(1):3-6. PubMed ID: 29227986 [No Abstract] [Full Text] [Related]
2. Targeting anti-apoptotic BCL-2 family proteins for cancer treatment. Zhang X; Liu X; Zhou D; Zheng G Future Med Chem; 2020 Apr; 12(7):563-565. PubMed ID: 32083493 [No Abstract] [Full Text] [Related]
3. Pioneering apoptosis-targeted cancer drug poised for FDA approval. Mullard A Nat Rev Drug Discov; 2016 Mar; 15(3):147-9. PubMed ID: 26931080 [No Abstract] [Full Text] [Related]
6. The rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy target. Brown JR Leuk Lymphoma; 2015; 56(10):2755-6. PubMed ID: 25971908 [No Abstract] [Full Text] [Related]
7. Mitochondrial function as an emerging 'target of interest' for cancer treatment. Sausville EA Curr Opin Investig Drugs; 2009 Jun; 10(6):523-5. PubMed ID: 19513940 [No Abstract] [Full Text] [Related]
9. In silico methods for designing antagonists to anti-apoptotic members of Bcl-2 family proteins. Sivakumar D; Richa T; Rajesh SS; Gorai B; Sivaraman T Mini Rev Med Chem; 2012 Oct; 12(11):1144-53. PubMed ID: 22697515 [TBL] [Abstract][Full Text] [Related]
10. Antagonizing Bcl-2's BH4 domain in cancer. Vervloessem T; La Rovere R; Bultynck G Aging (Albany NY); 2015 Oct; 7(10):748-9. PubMed ID: 26525307 [No Abstract] [Full Text] [Related]
11. The development of pro-apoptotic cancer therapeutics. Ziedan NI; Kadri H; Westwell AD Mini Rev Med Chem; 2008 Jun; 8(7):711-8. PubMed ID: 18537726 [TBL] [Abstract][Full Text] [Related]
13. Targeting mitochondria for cancer therapy. Hockenbery DM Environ Mol Mutagen; 2010 Jun; 51(5):476-89. PubMed ID: 20213841 [TBL] [Abstract][Full Text] [Related]
14. Cancer. DNA damage, deamidation, and death. Li C; Thompson CB Science; 2002 Nov; 298(5597):1346-7. PubMed ID: 12434041 [No Abstract] [Full Text] [Related]
15. BH4 domain of Bcl-2 as a novel target for cancer therapy. Liu Z; Wild C; Ding Y; Ye N; Chen H; Wold EA; Zhou J Drug Discov Today; 2016 Jun; 21(6):989-96. PubMed ID: 26631752 [TBL] [Abstract][Full Text] [Related]
16. Decoding and unlocking the BCL-2 dependency of cancer cells. Juin P; Geneste O; Gautier F; Depil S; Campone M Nat Rev Cancer; 2013 Jul; 13(7):455-65. PubMed ID: 23783119 [TBL] [Abstract][Full Text] [Related]
17. Drugs targeting Bcl-2 family members as an emerging strategy in cancer. Leber B; Geng F; Kale J; Andrews DW Expert Rev Mol Med; 2010 Sep; 12():e28. PubMed ID: 20822554 [TBL] [Abstract][Full Text] [Related]
18. Targeting mitochondria emerges as therapeutic strategy. Garber K J Natl Cancer Inst; 2005 Dec; 97(24):1800-1. PubMed ID: 16368937 [No Abstract] [Full Text] [Related]
19. Breaking down tumor defenses. Hockenbery D Chem Biol; 2004 Apr; 11(4):417-8. PubMed ID: 15123233 [No Abstract] [Full Text] [Related]